US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Miris AB Signs Distribution Agreement with Almazar Medical Corp to Expand Its Presence in the Middle East

Miris AB today announces the signing of a new distribution agreement with Almazar Medical Corp, a prominent provider of medical solutions in the Middle East. Through the partnership, Almazar Medical Corp gains the rights to distribute Miris products and solutions in Saudi Arabia, Bahrain, the United Arab Emirates, Kuwait, Qatar, Oman, Jordan, and Lebanon.Miris AB announces the signing of a new distribution agreement with Almazar Medical Corp. The agreement strengthens Miris’ commitment to improving neonatal nutrition globally and represents a significant expansion of the company’s presence

BioStock: Miris reporting record sales

The year-end report for 2022 shows a record for Miris' sales of analysis instruments that promote neonatal health. With a sales increase of 22 percent and gross margins of 75 percent, the medical technology company is well on its way to establishing Miris HMA as standard care for breast milk analysis. BioStock contacted CEO Camilla Myhre Sandberg to learn more about sales records, market potential and the outlook going forward.Read the interview with Miris' CEO Camilla Myhre Sandberg at biostock.se: https://www.biostock.se/en/2023/03/miris-reporting-record-sales/ This is a press

BioStock: Miris reports Q3 sales growth

Medtech company Miris reports sales growth for Q3, continuing the positive trend from the first half of the year. Sales increased by as much as 133 per cent and the company is well on its way to profitability as the net loss was halved compared to the same quarter 2021. Miris’ CEO Camilla Myhre Sandberg commented on the report and talked about the prospects for the company’s market-approved instruments for analysing breast milk.Read the interview with Miris' CEO Camilla Myhre Sandberg at biostock.se: https://www.biostock.se/en/2022/11/miris-reports-q3-sales-growth/ This is a press

BioStock: Miris boosts activity in the US and EU

Miris, a leader in breast milk analysis, has increased activity in the US and Europe after the pandemic has subsided. After the summer, the sales team has been into an intensive period with installations of instruments, training of hospital staff and exhibition and training at conferences. They also offer continued support and remote training via Miris Studio. BioStock contacted Miris Sales Manager Marie Ekholm to know more about the activities.Read the full article at biostock.se: https://www.biostock.se/en/2022/10/miris-boosts-activity-in-the-us-and-eu This is a press release from

Two more Miris HMA™ sold to Philippines

Almost 350 000 babies are born premature in Philippines every year. The country is number eighth in the world when it comes to the highest numbers of preterm births. Two more of the country’s 32 Milk Banks are now implementing Miris HMA™ to further secure the quality of the milk they will deliver to hospitals.Since 2017 Miris have been working with distributor Mediwide in Malaysia and Philippines and have seen a growing interest from these regions. Now, two more Milk Banks in Philippines has joined the Miris family. The Eastern Visayas Regional Medical Center (EVRMC) Human Milk Bank and the

First Miris HMA™ sold to Republic of Belarus

The knowledge of the importance of human milk for preterm babies is growing and with this increasing knowledge efforts are being made to increase the number of milk banks globally. For many countries this means opening of their first milk bank. By the end of 2021 Republic of Belarus is joining the milk banking community when it is opening its first Milk Bank. As many others, they have chosen Miris HMA™ to further secure the quality of the milk they will deliver to hospitals.At the end of 2021 the Republic of Belarus first donor human milk bank is planned to open. The milk bank will provide

Miris recommended reading

Comparison of Changes in Breast Milk Macronutrient Content During the First Month in Preterm and Term Infants (Breastfeeding Medicine.Jan 2020.56-6)This study aims to achieve a better understanding of the trend of maternal milk macronutrient levels by analyzing protein, lipid, carbohydrate, and energy content of the breast milk and investigate the possible confounders of macronutrient content during the first 4 weeks of lactation to meet the specific needs of babies, guide optimum fortification of maternal milk. https://www.liebertpub.com/doi/abs/10.1089/bfm.2019.0141

Croatia’s First Milk Bank buys Human Milk Analyzer™ – with support from UNICEF

Miris are delighted to have been able to assist with the first Human Milk Bank in Croatia with the Human Milk Analyzer™ at the University Hospital Zagreb. The medical device is donated by UNICEF, who also supports the milk bank project which will ensure the best possible care for premature babies and ill newborns.Miris, the global leader in human milk analysis, announces the sale of the Miris Human Milk Analyzer™ to the first Human Milk Bank in Croatia at University Hospital Zagreb that opened in August 2017. The Miris HMA™ measures the concentration of macronutrients in human milk, to

Miris expands its distributor network with a new partner in Kuwait

The MedTech company Miris, best known by its Miris Human Milk Analyzer™ (Miris HMA™), has announced an exciting new partnership with Advanced Medical German Company in GCC and MENA Region.Advanced Medical German Co is the latest distributor to carry Miris medical equipment and products for human milk analysis. Advanced Medical German Company is one of the leading distributors in medical products and services, with a mission of improving health care services. Its corporate office is located in Kuwait and operates business in GCC and also in international market. Its business structure is

Sales of Miris Human Milk Analyzer in the U.S. increasing

As milk analyzer company Miris received clearance by US Food and Drug Administration (FDA) to market its Miris Human Milk Analyzer™ (Miris HMA™) in December last year, clinicians in the U.S. for the first time have access to a test to analyze the nutrients in breast milk. With the FDA clearance Miris has seen an increased demand for the instrument and the development of target fortification strategies.During the first half of 2019, Miris has focused on entering the U.S. market. During the first six months of 2019 Miris sold and installed two HMA units for clinical use in the U.S. Now, in

Miris sell Human Milk Analyzer™ in Africa

The MedTech company Miris has sold the Miris Human Milk Analyzer™ (Miris HMA™) in South Africa, at the Stellenbosch University. That means doctors in South Africa for the first time have access to a clinical test to help analyze the nutritional content of human milk and thereby save lives by providing better neonatal care.Miris, the global leader in human milk analysis, today announces the first sale of the Miris Human Milk Analyzer™ in Africa at Stellenbosch University, Division of Human Nutrition, Faculty of Medicine and Health Sciences, South Africa. The Miris HMA™ measures the

Miris HMA™ installed in Singapore to provide invaluable help for premature babies

Miris announces the official release and Singapore's first clinical installation of Miris Human Milk Analyzer™ (Miris HMA™) at the milk bank KK Women’s and Children’s Hospital in Singapore. For the first time doctors in Singapore now have access to a diagnostic test to analyze the nutrients in human milk, which is crucial in the case of extreme premature or sick babies with particular nutritional needs.The Miris HMA™ enables the KK Human Milk Bank – the only Milk bank in Singapore - to perform a diagnostic test to measure nutrients in human milk. The KK Milk Bank supports the NICUs at KK

MedTech company Miris On Worldwide Business with Kathy Ireland

Miris’ has developed the Human Milk Analyzer ™ to improve global neonatal health. Miris CEO Camilla Myhre Sandberg, was exclusively interviewed by Kathy Ireland on Worldwide Business with Kathy Ireland . The show will be aired globally Bloomberg International on May 18 and 19.Kathy Ireland met with Miris’ CEO, Camilla Myhre Sandberg, and discussed how Miris are enabling clinicians to give preterm babies the best possible start, by supporting growth and reducing potential health issues later in life. One important key success factor is

Increased demand in the US for Miris Human Milk Analyzer

As milk analyzer company Miris received clearance by US Food and Drug Administration (FDA) to market its Miris Human Milk Analyzer™ (HMA) in December, doctors in the US for the first time have access to a test to help analyze the nutrients in breast milk. Miris HMA™ has been available since 2006 and the instrument is registered as a Medical Device in Europe, and Japan and is now also available in the US.The interest for optimizing nutrition for preterm babies is growing in USA and the FDA approval has already proven to give effect as several Neonatal Intensive Care Units in the US have

Miris launches the marketing campaign “The Swedish Way”

Human milk analysis company Miris today launched its marketing campaign, The Swedish Way. The campaign serves to raise international awareness of target fortification as a means to optimize the nutrition for premature babies.“With this campaign we wish to build opinion and educate how the target fortification is an essential part of ensuring the best possible outcome for a premature baby,” says Miris CEO Camilla Myhre Sandberg. “Sweden is a leading nation in neonatal care and the Swedish way of practicing individualized nutrition through target fortification is a key factor that we believe

Miris obtains ETL certification for HMA

Miris has obtained the ETL Listed Mark for its Human Milk Analyzer (HMA). This certification is a requirement to comply with the new updated IEC standards for medical devices in Europe and also in accordance with UL and CSA in North America.The ETL certification mark proves that the Human Milk Analyzer is compliant according to the new updated International Electrotechnical Commission standards (IEC) for medical devices in Europe. These are widely accepted product safety standards for electrical safety and electromagnetic compatibility, and the certification has been issued through the

Miris launches Miris Calibration Control Kit™

Today, Miris launches its proprietary standard solution Miris Calibration Control Kit (MCC). MCC is a consumable to be used as a control for the Miris Human Milk Analyzer (HMA). The kit is a mandatory procedure to be performed every day the HMA instrument is being used before analysis can start. The purpose is to control the calibration of the HMA instrument.Miris has strengthened its product portfolio with the Miris Calibration Control Kit (MCC). The kit consists of two different concentrations of a standard solution: Miris Calibration Control 1 (MCC1) and Miris Calibration Control 2 (MCC2)

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe